These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22245568)

  • 1. Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia.
    Orrù S; Orrù N; Manolakos E; Littera R; Caocci G; Giorgiani G; Bertaina A; Pagliara D; Giardini C; Nesci S; Locatelli F; Carcassi C; La Nasa G
    Hum Immunol; 2012 Mar; 73(3):282-6. PubMed ID: 22245568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
    Karabon L; Markiewicz M; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
    Immunogenetics; 2015 Jun; 67(5-6):295-304. PubMed ID: 25940108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.
    Pérez-García A; De la Cámara R; Román-Gómez J; Jiménez-Velasco A; Encuentra M; Nieto JB; de la Rubia J; Urbano-Ispizúa A; Brunet S; Iriondo A; González M; Serrano D; Espigado I; Solano C; Ribera JM; Pujal JM; Hoyos M; Gallardo D;
    Blood; 2007 Jul; 110(1):461-7. PubMed ID: 17384200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cytotoxic T-lymphocyte antigen-4 (CTLA-4) single nucleotide polymorphism in donors with clinical outcome after allogeneic hematopoietic stem cell transplantation: a meta-analysis.
    Wang Z; Zhang Y; Du Y; Song F; Gao S
    Hematology; 2021 Dec; 26(1):144-152. PubMed ID: 33491603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.
    Xiao H; Luo Y; Lai X; Fu S; Shi J; Tan Y; He J; Xie W; Zheng W; Wang LM; Zhang L; Liu L; Ye X; Yu X; Cai Z; Lin M; Huang H
    Haematologica; 2012 Dec; 97(12):1804-12. PubMed ID: 22733023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood.
    Hammrich J; Wittig S; Ernst T; Gruhn B
    Eur J Haematol; 2019 Mar; 102(3):251-255. PubMed ID: 30465728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.
    Hammrich J; Wittig S; Ernst T; Gruhn B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):587-592. PubMed ID: 29335768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 polymorphism and clinical outcome post allogeneic hematopoietic stem cell transplantation.
    Mossallam GI; Samra MA
    Hum Immunol; 2013 Dec; 74(12):1643-8. PubMed ID: 23973330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation.
    Karabon L; Markiewicz M; Kosmaczewska A; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Ciszak L; Jagoda K; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
    Immunol Lett; 2015 May; 165(1):52-9. PubMed ID: 25841352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
    Bosch-Vizcaya A; Pérez-García A; Brunet S; Solano C; Buño I; Guillem V; Martínez-Laperche C; Sanz G; Barrenetxea C; Martínez C; Tuset E; Lloveras N; Coll R; Guardia R; González Y; Roncero JM; Bustins A; Gardella S; Fernández C; Buch J; Gallardo D;
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):100-5. PubMed ID: 21703972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation.
    Bogunia-Kubik K; Middleton P; Norden J; Dickinson A; Lange A
    Int J Immunogenet; 2008 Jun; 35(3):207-13. PubMed ID: 18312595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSP70-hom gene polymorphism in allogeneic hematopoietic stem-cell transplant recipients correlates with the development of acute graft-versus-host disease.
    Bogunia-Kubik K; Lange A
    Transplantation; 2005 Apr; 79(7):815-20. PubMed ID: 15818324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Genetic Variations in the
    Karabon L; Markiewicz M; Chrobot K; Dzierzak-Mietla M; Pawlak-Adamska E; Partyka A; Koclega A; Kyrcz-Krzemien S; Frydecka I
    J Immunol Res; 2018; 2018():3826989. PubMed ID: 29577049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
    Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor.
    Qin XY; Wang Y; Li GX; Qin YZ; Wang FR; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    J Transl Med; 2016 Apr; 14():100. PubMed ID: 27118383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between interleukin-10 promoter gene polymorphisms and acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Cho IH; Song YK; Kim MG; Han N; Kim T; Oh JM
    Hematology; 2015 Apr; 20(3):121-8. PubMed ID: 25116082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Cytotoxic T-Lymphocyte Antigen 4 Gene Polymorphisms and Torque Teno Virus Infection After Hematopoietic Stem Cell Transplantation.
    Ramzi M; Iravani Saadi M; Zarei T; Yaghobi R; Arandi N
    Exp Clin Transplant; 2021 Mar; 19(3):259-263. PubMed ID: 29251582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
    Front Immunol; 2018; 9():109. PubMed ID: 29456530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
    Karabon L; Wysoczanska B; Bogunia-Kubik K; Suchnicki K; Lange A
    Hum Immunol; 2005 Jun; 66(6):700-10. PubMed ID: 15993715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.